Cell signaling mechanisms by which geniposide regulates insulin-degrading enzyme expression in primary cortical neurons

CNS and Neurological Disorders - Drug Targets

Volumn 14, Issue 3, 2015, Pages 370-377

  Zhang, Yonglan ^a   Xia, Zhining ^a   Liu, Jianhui ^b,c   Yin, Fei ^b,c  

^a CHONGQING UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

^c CHONGQING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

Author keywords

Alzheimer s disease; Glucagon like peptide 1; Insulin degrading enzyme; amyloid

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6, 7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL) PYRAZOLO [3, 4 D] PYRIMIDINE; GENIPOSIDE; INSULINASE; N [2 (4 BROMOCINNAMYLAMINO) ETHYL] 5 ISOQUINOLINESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; CENTRAL NERVOUS SYSTEM AGENTS; CYCLIC AMP DEPENDENT PROTEIN KINASE; EGFR PROTEIN, RAT; EPIDERMAL GROWTH FACTOR RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; IRIDOID; NERVE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; CELL CULTURE; CELL NUCLEUS; CYTOSOL; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NERVE CELL; ONCOGENE SRC; PC12 CELL LINE; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CELL NUCLEUS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; CEREBRAL CORTEX; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSOL; FORKHEAD TRANSCRIPTION FACTORS; GENES, SRC; INSULYSIN; IRIDOIDS; NERVE TISSUE PROTEINS; NEURONS; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84929257109     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527314666141229110156     Document Type: Article

References (35)

1. Selkoe DJ. The origins of Alzheimer disease: a is for amyloid. JAMA 2000; 283(12): 1615-7.
2. Brindle N, George-Hyslop PS. The genetics of Alzheimer's disease. Methods Mol Med 2000; 32: 23-43.
3. Tanzi RE, George-Hyslop PS, Gusella JF. Molecular genetics of Alzheimer disease amyloid. J Biol Chem 1991; 266(31): 20579-82.
4. Savage MJ, Trusko SP, Howland DS, et al. Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J Neurosci 1998; 18(5): 1743-52.
5. Dovey HF, John V, Anderson JP, et al. Functional gammasecretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 2001; 76(1): 173-81.
6. Wang S, Wang R, Chen L, et al. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelinconverting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem 2010; 115(1): 47-57.
7. Kurochkin IV. Insulin-degrading enzyme: embarking on amyloid destruction. Trends Biochem Sci 2001; 26(7): 421-5.
8. Qiu WQ, Walsh DM, Ye Z, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 1998; 273(49): 32730-8.
9. Bernstein HG, Ansorge S, Riederer P, et al. Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci Lett 1999; 263(2-3): 161-4.
10. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the betaamyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003; 100(7): 4162-7.
11. Leissring MA, Farris W, Chang AY, et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 2003; 40(6): 1087-93.
12. Vekrellis K, Ye Z, Qiu WQ, et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 2000; 20(5): 1657-65.
13. Liu J, Yin F, Zheng X, Jing J, Hu Y. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway. Neurochem Int 2007; 51(6-7): 361-9.
14. Yin F, Zhang Y, Guo L, Kong S, Liu J. Geniposide regulates insulin-degrading enzyme expression to inhibit the cytotoxicity of Abeta(1)(-)(4)(2) in cortical neurons. CNS Neurol Disord Drug Targets 2012; 11(8): 1045-51.
15. Liu J, Zhang Y, Deng X, Yin F. Geniposide decreases the level of Abeta1-42 in the hippocampus of streptozotocin-induced diabetic rats. Acta Biochim Biophys Sin 2013; 45(9): 787-91.
16. Yin F, Liu J, Zheng X, Guo L, Xiao H. Geniposide induces the expression of heme oxygenase-1 via PI3K/Nrf2-signaling to enhance the antioxidant capacity in primary hippocampal neurons. Biol Pharmaceut Bull 2010; 33(11): 1841-6.
17. Zhang L, Ding Q, Wang Z. Nuclear respiratory factor 1 mediates the transcription initiation of insulin-degrading enzyme in a TATA box-binding protein-independent manner. PloS One 2012; 7(8): e42035.
18. Doyle ME, Egan JM. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 2007; 113(3): 546-93.
19. Buteau J, Spatz ML, Accili D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass. Diabetes 2006; 55(5): 1190-6.
20. Du J, Zhang L, Liu S, et al. PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons. Biochem Biophys Res Commun 2009; 383(4): 485-90.
21. Kuo W-H, Chou F-P, Young S-C, Chang Y-C, Wang C-J. Geniposide activates GSH S-transferase by the induction of GST M1 and GST M2 subunits involving the transcription and phosphorylation of MEK-1 signaling in rat hepatocytes. Toxicol Appl Pharmacol 2005; 208(2): 155-62.
22. Gao C, Liu Y, Jiang Y, Ding J, Li L. Geniposide ameliorates learning memory deficits, reduces Tau phosphorylation, and decreases apoptosis via GSK3beta pathway in streptozotocininduced Alzheimer rat model. Brain Pathol 2014; 24(3): 261-9.
23. Yu Y, Xie ZL, Gao H, et al. Bioactive iridoid glucosides from the fruit of Gardenia jasminoides. J Nat Prod 2009; 72(8): 1459-64.
24. Yamazaki M, Sakura N, Chiba K, Mohri T. Prevention of the neurotoxicity of the amyloid beta protein by genipin. Biol Pharm Bull 2001; 24(12): 1454-5.
25. Liu JH, Yin F, Guo LX, Deng XH, Hu YH. Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway. Acta Pharmacol Sin 2009; 30(2): 159-65.
26. Yin F, Liu JH, Zheng XX, Guo LX. GLP-1 receptor plays a critical role in geniposide-induced expression of heme oxygenase-1 in PC12 cells. Acta Pharmacol Sin 2010; 31(5): 540-5.
27. Yamazaki M, Chiba K, Satoh K. Neuro2a cell death induced by 6- hydroxydopamine is attentuated by genipin. J Health Sci 2008; 54(6): 638-44.
28. Ha KS, Kim KM, Kwon YG, et al. Nitric oxide prevents 6- hydroxydopamine-induced apoptosis in PC12 cells through cGMPdependent PI3 kinase/Akt activation. FASEB J 2003; 17(9): 1036- 47.
29. Chen Z, Zhong C. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Progr Neurobiol 2013; 108: 21-43.
30. Quan Q, Wang J, Li X, Wang Y. Ginsenoside Rg1 decreases Abeta(1-42) level by upregulating PPARgamma and IDE expression in the hippocampus of a rat model of Alzheimer's disease. PloS One 2013; 8(3): e59155.
31. McCarty MF. Toward prevention of Alzheimers disease--potential nutraceutical strategies for suppressing the production of amyloid beta peptides. Med Hypotheses 2006; 67(4): 682-97.
32. Du J, Sun B, Chen K, Fan L, Wang Z. Antagonist of peroxisome proliferator-activated receptor gamma induces cerebellar amyloidbeta levels and motor dysfunction in APP/PS1 transgenic mice. Biochem Biophys Res Commun 2009; 384(3): 357-61.
33. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256(5054): 184-5.
34. Reitz C. Alzheimer's disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimer's Dis 2012; 2012: 369808.
35. Cook DG, Leverenz JB, McMillan PJ, et al. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 2003; 162(1): 313-9.